Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ · Healthcare
Kiniksa Pharmaceuticals International, plc Gross Profit 2021–2025
Kiniksa Pharmaceuticals International, plc annual/quarterly gross profit history and growth rate from 2021 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Kiniksa Pharmaceuticals International, plc gross profit for the quarter ending March 31, 2026 was 193.5 M, a 61.34% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc gross profit for the twelve months ending March 31, 2026 was 612.2 M, a 93.94% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc annual gross profit for 2025 was 599.9 M, a 65.57% increase from 2024.
- Kiniksa Pharmaceuticals International, plc annual gross profit for 2024 was 362.3 M, a 52.98% increase from 2023.
- Kiniksa Pharmaceuticals International, plc annual gross profit for 2023 was 236.9 M, a 20.06% increase from 2022.
- Kiniksa Pharmaceuticals International, plc annual gross profit for 2022 was 197.3 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Kiniksa Pharmaceuticals International, plc Gross Profit — FAQ
Kiniksa Pharmaceuticals International, plc (KNSA) gross profit over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
What is Kiniksa Pharmaceuticals International, plc's gross profit?
Kiniksa Pharmaceuticals International, plc (KNSA) reported gross profit of $600M for fiscal 2025.
Where can I see KNSA's gross profit history?
The chart and table above show Kiniksa Pharmaceuticals International, plc's gross profit by year and by quarter, including the growth rate.